Correlation Between Novartis and Amgen
Can any of the company-specific risk be diversified away by investing in both Novartis and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Amgen Inc, you can compare the effects of market volatilities on Novartis and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Amgen.
Diversification Opportunities for Novartis and Amgen
Almost no diversification
The 3 months correlation between Novartis and Amgen is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Novartis i.e., Novartis and Amgen go up and down completely randomly.
Pair Corralation between Novartis and Amgen
Considering the 90-day investment horizon Novartis AG ADR is expected to generate 0.89 times more return on investment than Amgen. However, Novartis AG ADR is 1.12 times less risky than Amgen. It trades about 0.23 of its potential returns per unit of risk. Amgen Inc is currently generating about 0.2 per unit of risk. If you would invest 9,395 in Novartis AG ADR on December 28, 2024 and sell it today you would earn a total of 1,862 from holding Novartis AG ADR or generate 19.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Novartis AG ADR vs. Amgen Inc
Performance |
Timeline |
Novartis AG ADR |
Amgen Inc |
Novartis and Amgen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novartis and Amgen
The main advantage of trading using opposite Novartis and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |